19 Feb Incretin based drugs and the risk of pancreatic cancer
In this large population study co-authored by Therapeutics Initiative researcher Dr. Colin Dormuth, "the use of incretin based drugs was not associated with an increased risk of pancreatic cancer compared with sulfonylureas. Although this potential...